| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |